The influence of age, menstrual state and body mass index on the relation between osteopenia and osteoporosis associated with breast cancer

References

• Abdel-Razeq H. 2011. Caring for the breast cancer survivor. The American Journal of Medicine 124:e11.
   PubMed Web of Science ®Google Scholar
• Andreopoulou P, Division of Endocrinology, Department of Medicine, Weill Cornell Medicine, New York, NY, USA 2019. Bone health in patients with breast cancer. Oncology & Hematology Review (US) 15:16–19.
   Google Scholar
• Biglia N, Peano E, Sgandurra P, Moggio G, Pecchio S, Maggiorotto F, Sismondi P. 2013. Body mass index (BMI) and breast cancer: impact on tumor histopathologic features, cancer subtypes and recurrence rate in pre and postmenopausal women. Gynecological Endocrinology 29:263–267.
   PubMed Web of Science ®Google Scholar
• Bruyère O, Bergmann P, Cavalier E, Gielen E, Goemaere S, Kaufman J, et al. 2017. Skeletal health in breast cancer survivors. Maturitas 105:78–82.
   PubMed Web of Science ®Google Scholar
• Cecchini RS, Costantino JP, Cauley JA, Cronin WM, Wickerham DL, Land SR, et al. 2012. Body mass index and the risk for developing invasive breast cancer among high-risk women in NSABP P-1 and STAR breast cancer prevention trials. Cancer Prevention Research 5:583–592.
   PubMed Web of Science ®Google Scholar
• Cepa M, Vaz C. 2015. Management of bone loss in postmenopausal breast cancer patients treated with aromatase inhibitors. Acta Reumatologica Portuguesa 40:323–330.
   PubMed Web of Science ®Google Scholar
• Chan DSM, Vieira AR, Aune D, Bandera EV, Greenwood DC, McTiernan A, Rosenblatt DN, et al. 2014. Body mass index and survival in women with breast cancer-systematic literature review and meta-analysis of 82 follow-up studies. Annals of Oncology 25:1901–1914.
   PubMed Web of Science ®Google Scholar
• Chen B, Guo L, Li K, Xiao W, Li Y, Li C, et al. 2021. Association of body mass index with somatic mutations in breast cancer. Frontiers in Oncology 11:613933.
   PubMed Web of Science ®Google Scholar
• Chen C, Chen Q, Nie B, Zhang H, Zhai H, Zhao L, et al. 2020. Trends in bone mineral density, osteoporosis and osteopenia among U.S. adults with prediabetes, 2005-2014. Diabetes Care 43:1008–1015.
   PubMed Web of Science ®Google Scholar
• Cheung AM, Heisey R, Srighanthan J. 2013. Breast cancer and osteoporosis. Current Opinion in Endocrinology, Diabetes, and Obesity 20:532–538.
   Google Scholar
• Guo Y, Andersen SW, Shu X, Michailidou K, Bolla MK, Wang Q, et al. 2016. Genetically predicted body mass index and breast cancer risk: Mendelian randomization analyses of data from 145,000 women of European descent. PLoS Medicine 13:e1002105.
   PubMed Web of Science ®Google Scholar
• Kalder M, Hadji P. 2014. Breast cancer and osteoporosis-management of cancer treatment-induced bone loss in postmenopausal women with breast cancer. Breast Care 9:312–317.
   PubMed Web of Science ®Google Scholar
• Katz S. 2013. Prevention, detection and treatment of osteopenia and osteoporosis. Gastroenterology and Hepatology 9:176–178.
   Google Scholar
• Lee S, Yoo J, Lee Y, Park J, Won S, Yeom J, Im JW, et al. 2020. Risk of osteoporosis fracture in patients with breast cancer: meta-analysis. Journal of Bone Metabolism 27:27–34.
   PubMedGoogle Scholar
• Martínez P, Galve E, Arrazubi V, Sala MÁ, Fernández S, Pérez CE, et al. 2019. Impact of an osteoporosis specialized unit on bone health in breast cancer survivals treated with aromatase inhibitors. Reumatologia Clinica 15:211–217.
   PubMed Web of Science ®Google Scholar
• Mazocco L, Chagas P. 2017. Association between body mass index and osteoporosis in women from northwestern Rio Grande do Sul. Revista Brasileira de Reumatologia 57:299–305.
   PubMedGoogle Scholar
• Mincey BA, Moraghan TJ, Perez EA. 2000. Prevention and treatment of osteoporosis in women with breast cancer. Mayo Clinic Proceedings 75:821–829.
   PubMed Web of Science ®Google Scholar
• Molah Karim SA, Ghalib HHA, Fattah FHR, Gubari MIM, Majeed AB. 2015. Height, weight and body mass index association with breast cancer risk in Iraqi Kurdish women. Case Studies in Surgery 1:7.
   Google Scholar
• Noda MF, Aleaga ZG, Hernández MCR, Rodríguez LEM, Braojos IMP, Varela IS, et al. 2016. Body mass index and clinical and pathological characteristics of breast cancer patients. Revista Cubana de Endocrinología 27:45–62.
   Google Scholar
• Nuttall FQ. 2015. Body mass index, obesity, BMI and health: a critical review. Nutrition Today 50:117–128.
   PubMedGoogle Scholar
• Patel V, James M, Frampton C, Robinson B, Davey V, Timmings L. 2020. Body mass index and outcomes in breast cancer treated with breast conservation. International Journal of Radiation Oncology, Biology, Physics 106:369–376.
   PubMed Web of Science ®Google Scholar
• Poznak CHV, Sauter NP. 2005. Clinical management of osteoporosis in women with a history of breast carcinoma. Cancer 104:443–456.
   PubMed Web of Science ®Google Scholar
• Poznak CHV. 2015. Bone health in adults treated with endocrine therapy for early breast or prostate cancer. American Society of Clinical Oncology Educational Book e567–e574.
   Google Scholar
• Ramchand SK, Cheung Y, Yeo B, Grossmann M. 2019. The effects of adjuvant endocrine therapy on bone health in women with breast cancer. The Journal of Endocrinology 241:R111–R124.
   PubMed Web of Science ®Google Scholar
• Reeves KW, Faulkner K, Modugno F, Hillier TA, Bauer DC, Ensrud KE, Cauley JA, Study of Osteoporotic Fractures Research Group 2007. Body mass index and mortality among older breast cancer survivors in the study of osteoporotic fractures. Cancer Epidemiology, Biomarkers & Prevention 16:1468–1473.
   PubMed Web of Science ®Google Scholar
• Roux C. 2009. Osteopenia: is it a problem. International Journal of Clinical Rheumatology 4:651–655.
   Google Scholar
• Royal Australian College of General Practitioners (RACGP). 2017. Osteoporosis prevention, diagnosis and management in postmenopausal women and men over 50 years of age. 2nd edition. East Melbourne, Victoria, Australia. www.racgp.org.au.
   Google Scholar
• Ruzycki SM, Nixon NA. 2018. Bone health after diagnosis of breast cancer. Canadian Medical Association Journal = Journal de L'Association Medicale Canadienne 190:E1452.
   PubMed Web of Science ®Google Scholar
• Saleh K, Carton M, Dieras V, Heudel P-E, Brain E, D'Hondt V, et al. 2021. Impact of body mass index on overall survival in patients with metastatic breast cancer. Breast 55:16–24.
   PubMed Web of Science ®Google Scholar
• Shapiro C, Van Poznak C, Lacchetti C, Kirshner J, Eastell R, Gagel R, Smith S, et al. 2019. Management of osteoporosis in survivors of adult cancers with nonmetastatic disease: ASCO clinical practice guideline. Journal of Clinical Oncology 37:2916–2946.
   PubMed Web of Science ®Google Scholar
• Shapiro CL. 2020. Osteoporosis: a long-term and late-effect of breast cancer treatment. Cancers 12:3094.
   PubMed Web of Science ®Google Scholar
• Shieh Y, Scott CG, Jensen MR, Norman AD, Bertrand KA, Pankratz VS, et al. 2019. Body mass index, mammographic density and breast cancer risk by estrogen receptor subtype. Breast Cancer Research 21:48.
   PubMed Web of Science ®Google Scholar
• Sun L, Zhu Y, Qian Q, Tang L. 2018. Body mass index and prognosis of breast cancer. An analysis by menstruation status when breast cancer diagnosis. Medicine 26:e11220.
   Google Scholar
• Tamaki K, Tamaki N, Terukina S, Kamada Y, Uehara K, Arakaki M, et al. 2014. The correlation between body mass index and breast cancer risk or estrogen receptor status in Okinawan women. The Tohoku Journal of Experimental Medicine 234:169–174.
   PubMed Web of Science ®Google Scholar
• The Premenopausal Breast Cancer Collaborative Group (PBCCG). 2018. Association of body mass index and age with subsequent breast cancer risk in premenopausal women. JAMA Oncology 4:e18177.
   Web of Science ®Google Scholar
• Varacallo M, Pizzutillo P. Osteopenia. StatPearls Publishing LLC. NCBI bookshelf. 2018. ID NBK499878. https://www.ncbi.nlm.nih.gov/books/NBK499878/?report=printable.
   Google Scholar
• Wang K, Wu Y, Zhang X, Chen L, Zhu W, Zhang A, et al. 2019. Clincopathologic and prognostic significance of body mass index (BMI) among breast cancer patients in Western China: a retrospective multicenter cohort based on Western China clinical cooperation group (WCCCG). BioMed Research International 2019:1–14.
   Web of Science ®Google Scholar
• Wang X, Hui T, Wang M, Liu H, Li R, Song Z. 2019. Body mass index at diagnosis as a prognostic factor for early-stage invasive breast cancer after surgical resection. Oncology Research and Treatment 42:190–196.
   Web of Science ®Google Scholar
• Weisell RC. 2002. Body mass index as an indicator of obesity. Asia Pacific Journal of Clinical Nutrition 11:S681–S684.
   PubMedGoogle Scholar
• Zaman K, Thürlimann B, Huober J, Schönenberger A, Pagani O, Lüthi J, et al. 2012. Bone mineral density in breast cancer patients treated with adjuvant letrozole, tamoxifen or sequences of letrozole and tamoxifen in the BIG 1-98 study (SAKK 21/07). Annals of Oncology 23:1474–1481.
   PubMed Web of Science ®Google Scholar